VIA
FPRX
Vident Investment Advisory’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-133,272
| Closed | -$1.86M | – | 966 |
|
|
2018
Q3 | $1.86M | Sell |
133,272
-8,882
| -6% | -$124K | 0.07% | 343 |
|
|
2018
Q2 | $2.25M | Buy |
142,154
+60,608
| +74% | +$958K | 0.09% | 307 |
|
|
2018
Q1 | $1.41M | Buy |
81,546
+21,779
| +36% | +$376K | 0.06% | 349 |
|
|
2017
Q4 | $1.31M | Buy |
59,767
+18,994
| +47% | +$416K | 0.06% | 332 |
|
|
2017
Q3 | $1.67M | Sell |
40,773
-46,836
| -53% | -$1.92M | 0.09% | 298 |
|
|
2017
Q2 | $2.64M | Buy |
87,609
+22,940
| +35% | +$691K | 0.22% | 138 |
|
|
2017
Q1 | $2.34M | Sell |
64,669
-872
| -1% | -$31.5K | 0.23% | 195 |
|
|
2016
Q4 | $3.28M | Sell |
65,541
-9
| -0% | -$451 | 0.4% | 45 |
|
|
2016
Q3 | $3.44M | Buy |
65,550
+48,935
| +295% | +$2.57M | 0.46% | 24 |
|
|
2016
Q2 | $687K | Sell |
16,615
-18,681
| -53% | -$772K | 0.1% | 323 |
|
|
2016
Q1 | $1.43K | Buy |
35,296
+16,412
| +87% | +$667 | 0.09% | 338 |
|
|
2015
Q4 | $784K | Buy |
+18,884
| New | +$784K | 0.1% | 334 |
|